Fig. 11
From: NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses
(A) Pan-cancer correlation analysis of NOX4 expression with immune checkpoint genes. (B) Pan-cancer correlation analysis of NOX4 expression with immune pathway marker genes reveals significant associations (*P < 0.05).
